Biological Product (Except Diagnostic) Manufacturing federal obligations in FY2025

What the 325414–FY2025 join is

NAICS 325414 and fiscal year 2025 meet in one yearlyTrend cell. $13,183,433,554.11 is the obligation sum tagged to that pair. It is not the FY2024 325414 cell on this slice, not pharmaceutical preparation manufacturing (325412), and not an outlay. The two 325414 years share an industry extract; they do not share a yearlyTrend row.

A second-year cell beside a first-year cell can look like a decline or a rise. This page reports $13,183,433,554.11 as given for FY2025. Ranking years as winners or losers is not the join. Correlation with product news is not causation.

FY2025 beside the 325414 longer book

49.0% of $26,909,109,940.38 landed in this cell. The FY2024 325414 pair on this slice is a different row. Adding that row into $13,183,433,554.11 would double-count. The industry hub at /industries/325414/ is the parent without a FY2025 filter. FY2025 federal spending at /fiscal-years/2025/ is the parent without a 325414 filter.

An open fiscal year can restated later. Cite $13,183,433,554.11 as obligations, not as payments already cleared on a named lot.

Award records on 325414 are not a FY2025 census

1,274 is the Biological Product (Except Diagnostic) Manufacturing award-record count published with the industry extract, not a count of FY2025 instruments. The same 1,274 appears on the FY2024 325414 page because it is extract-wide. Unique recipients are unpublished.

What the 325414 FY2025 table omits

No outlays, no product split, no named primes, no FEC overlay. Campaign donations do not fund these USAspending obligations. All industries (/industries/) and All spending ties (/ties/) hold other keys.

Where to read the 325414–FY2025 pair

Open NAICS 325414 (/industries/325414/) for the industry hub, FY2025 federal spending (/fiscal-years/2025/) for the year hub, All industries (/industries/) for every industry, and All spending ties (/ties/) for other joins. Keep Biological Product (Except Diagnostic) Manufacturing and FY2025 in the citation.

Reuse $13,183,433,554.11 only with NAICS 325414 and fiscal year 2025 in the same sentence. The 1,274 award-record count stays on the industry extract. Original filings remain on USAspending.gov. Keep Biological Product (Except Diagnostic) Manufacturing and FY2025 together when citing $13,183,433,554.11. NAICS 325414's extract-wide award-record count is 1,274, not a FY2025 census. Obligations of $13,183,433,554.11 are not outlays. Original filings remain on USAspending.gov for this 325414 × FY2025 pair. Do not add parent hubs into this yearlyTrend cell. Campaign-finance tables do not fund these USAspending obligations. The 49.0% share is $13,183,433,554.11 divided by the extract-wide $26,909,109,940.38, not a budget score. Unique recipients remain unpublished on this Biological Product (Except Diagnostic) Manufacturing FY2025 join. Agency and place-of-performance splits are omitted from this packet. Quote NAICS 325414, fiscal year 2025, and $13,183,433,554.11 in one sentence. The All industries index and All spending ties index are larger than this cell. A later USAspending ingest can restate $13,183,433,554.11 without changing the join keys. Keep Biological Product (Except Diagnostic) Manufacturing and FY2025 together when citing $13,183,433,554.11. NAICS 325414's extract-wide award-record count is 1,274, not a FY2025 census. Obligations of $13,183,433,554.11 are not outlays. Original filings remain on USAspending.gov for this 325414 × FY2025 pair. Do not add parent hubs into this yearlyTrend cell. Campaign-finance tables do not fund these USAspending obligations. The 49.0% share is $13,183,433,554.11 divided by the extract-wide $26,909,109,940.38, not a budget score. Unique recipients remain unpublished on this Biological Product (Except Diagnostic) Manufacturing FY2025 join. Agency and place-of-performance splits are omitted from this packet. Quote NAICS 325414, fiscal year 2025, and $13,183,433,554.11 in one sentence.

Questions

How much did biological product manufacturing obligate in FY2025?

USAspending.gov records $13,183,433,554.11 in Biological Product (Except Diagnostic) Manufacturing obligations for FY2025 under NAICS 325414. That yearlyTrend total is not an outlay and not the industry's $26,909,109,940.38 extract-wide sum. Keep Biological Product (Except Diagnostic) Manufacturing and FY2025 on the same citation as $13,183,433,554.11.

Is $13,183,433,554.11 the same as the FY2024 325414 cell?

No. FY2025 is 49.0% of NAICS 325414's $26,909,109,940.38 extract-wide total. The FY2024 325414 join is a separate yearlyTrend row. Do not substitute one year for the other. 1,274 is the industry extract award-record count, not a FY2025 headcount.

Do 1,274 awards mean 1,274 FY2025 biologic contracts?

No. 1,274 is the 325414 extract award-record count, not a FY2025-only census. The packet does not name makers. Obligations of $13,183,433,554.11 are not outlays. The pair is NAICS 325414 plus FY2025. The pair is NAICS 325414 plus FY2025.

Does this include outlays or campaign donations?

No. $13,183,433,554.11 is an obligation aggregate from USAspending.gov. Outlays are unpublished. FEC contribution tables do not fund these awards. USAspending.gov remains the source for NAICS 325414 in FY2025. The pair is NAICS 325414 plus FY2025.